[Form 4] IonQ, Inc. Insider Trading Activity

Rhea-AI Filing Summary

IonQ director Kathryn K. Chou received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Chou beneficially owns a total of 67,628 shares directly.

Key terms of the RSU award:

• Vesting occurs at the earlier of: - 2026 Annual Meeting (or day prior if service ends at meeting) - June 18, 2026
• Vesting is contingent on continued service as Board member
• RSUs were granted at $0 exercise price

This Form 4 filing represents a standard director equity compensation grant, likely part of IonQ's annual board member compensation package. The transaction was executed under normal circumstances with no indication of any Rule 10b5-1 trading plan involvement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chou Kathryn K.

(Last) (First) (Middle)

C/O IONQ, INC.

4505 CAMPUS DRIVE

(Street)

COLLEGE PARK MD 20740

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IonQ, Inc. [ IONQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		A		5,513(1)	A	$0	67,628	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the date of the 2026 Annual Meeting (or the date immediately prior to the 2026 Annual Meeting if the Reporting Person's service as a director ends at such Annual Meeting), or (ii) June 18, 2026, subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

	/s/ Stacey Giamalis, Attorney-in-Fact	06/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many IONQ shares did Director Kathryn Chou receive on June 18, 2025?

Director Kathryn Chou received 5,513 restricted stock units (RSUs) of IONQ common stock on June 18, 2025, awarded at a price of $0.

What are the vesting terms for IONQ Director Kathryn Chou's RSU grant?

The RSUs will vest in full on the earlier of (i) the date of the 2026 Annual Meeting (or the day before if her service ends at that meeting), or (ii) June 18, 2026, subject to her continued service as a Board member through the vesting date.

How many IONQ shares does Kathryn Chou own after the June 18, 2025 transaction?

Following the RSU grant transaction, Kathryn Chou beneficially owns 67,628 shares of IONQ common stock held directly (Form: Direct Ownership).

Who filed the Form 4 for IONQ Director Kathryn Chou?

The Form 4 was signed by Stacey Giamalis as Attorney-in-Fact for Kathryn Chou on June 18, 2025.